Advisory Board January 22, 2025
CMS last week announced the next 15 drugs to be included in Medicare price negotiations, a list that includes the diabetes and weight-loss drugs Ozempic and Wegovy
4 things leaders need to know about high-cost drugs
CMS announces next 15 drugs for price negotiations
The list of drugs includes:
- Ozempic, Rybelsus, and Wegovy for Type 2 diabetes and weight loss
- Trelegy Ellipta, an asthma treatment
- Xtandi, for prostate cancer
- Pomalyst, a chemotherapy drug
- Ibrance, a breast cancer drug
- Ofev, for idiopathic pulmonary fibrosis
- Linzess, a chronic constipation drug
- Calquence, a cancer drug
- Austedo and Austedo XR for Huntington’s disease
- Breo Ellipta, a COPD drug
- Tradjenta, a diabetes drug
- Xifaxan, for diarrhea and irritable bowel syndrome
- Vraylar, an antipsychotic drug ...
Today's Sponsors
Today's Sponsor